The Maudsley Prescribing Guidelines in Psychiatry [NOOK Book]

Overview

This book is the essential guide for anyone responsible for prescribing, dispensing or
administering drugs for patients with mental health disorders. All the evidence has been
reviewed and summarised succinctly by an expert team of psychiatrists and pharmacists.

The evidence base for drug treatments in ...

See more details below
The Maudsley Prescribing Guidelines in Psychiatry

Available on NOOK devices and apps  
  • NOOK Devices
  • NOOK HD/HD+ Tablet
  • NOOK
  • NOOK Color
  • NOOK Tablet
  • Tablet/Phone
  • NOOK for Windows 8 Tablet
  • NOOK for iOS
  • NOOK for Android
  • NOOK Kids for iPad
  • PC/Mac
  • NOOK for Windows 8
  • NOOK for PC
  • NOOK for Mac
  • NOOK Study
  • NOOK for Web

Want a NOOK? Explore Now

NOOK Book (eBook)
$49.99
BN.com price
(Save 42%)$87.00 List Price
Note: This NOOK Book can be purchased in bulk. Please email us for more information.

Overview

This book is the essential guide for anyone responsible for prescribing, dispensing or
administering drugs for patients with mental health disorders. All the evidence has been
reviewed and summarised succinctly by an expert team of psychiatrists and pharmacists.

The evidence base for drug treatments in psychiatry ranges from meta-analyses and
randomised controlled clinical trials to single case reports, from NICE guidelines to
individual SPCs. Where to look for information when transferring a patient from one
drug to another or when dealing with a complex patient (for example, with co-morbid
epilepsy or liver disease or HIV infection)? The Maudsley Prescribing Guidelines are
established as the leading clinical relevant reference for handling complex prescribing
problems and for formulating prescribing policy.

This new edition makes greater use of tables and boxes to facilitate quick reference and
includes new sections on cytochrome-mediated interactions, psychiatric side effects of
non-psychotropic drugs and on GBL and GHB dependence.

Chapters cover plasma monitoring, schizophrenia, bipolar disorder, depression and
anxiety, children and adolescents, substance misuse and special patient groups. Each
section has a full reference list. The book covers prescribing drugs outside their licensed
indications and their interaction with substances such as alcohol, nicotine and caffeine.

Trainees will gain important information regarding the rational, safe and effective use
of medications for patients with mental illness. Experienced clinicians will find excellent
guidance regarding more complex issues that they may not encounter regularly.

Praise for previous editions:
“I would regard this book as mandatory for any pharmacist directly involved in the
care of patients with a psychiatric diagnosis, be they primary or secondary care-based.”
The Pharmaceutical Journal

“An excellent book and a ‘must’ for practising psychiatrists… not only will the rational
prescribing of psychotropic drugs drastically improve but, more importantly, the
patient will certainly benefit.”
Human Psychopharmacology

Read More Show Less

Editorial Reviews

Doody's Review Service
Reviewer: Brett C. Plyler, M.D.(Northwestern Memorial Hospital)
Description: This is the eleventh edition of a guide to prescribing psychiatric medication for patients with mental health disorders.
Purpose: The purpose is to provide clinicians with practical advice on prescribing psychiatric medications in regularly encountered clinical situations.
Audience: The audience includes all clinicians who prescribe psychiatric medication. It can be used by both trainees and experienced providers.
Features: The book covers a far-reaching range of topics in its prescribing guidelines. The usual conditions are all here — schizophrenia, mood disorders, anxiety, and child/adolescent prescribing. A nice section covers special conditions — eating disorders, dementia, etc. — that are more difficult to treat. The data used to form the guidelines is composed of the latest studies, literature reviews, and expert opinions. Tables throughout each section compare and contrast different data on each medication. The book has color tabs on the sides of the pages to allow readers to quickly flip to a particular section, and the references are extensive. The book presents a large amount of information in an efficient and organized manner.
Assessment: This is an excellent reference for prescribing medications. Besides the usual, familiar treatment guidelines, it tackles more specialized topics such as how and why to switch from an SSRI to an SNRI or what medication to try next if a patient develops an elevated prolactin level on risperdone. The special patients section is also invaluable, from what to do for hepatic impairment to how useful SSRIs are in eating disorders. My problems with this book are minor. Sometimes all of the data for a particular topic is not in one section. For example, in the discussion of SSRIs, the information on treatment of sexual dysfunction is contained in the chapter on schizophrenia, and, at times, there is too much data contained in the tables. It would have been helpful in the special patients section if the page labels denoted each subsection so I could flip to the one I needed quickly. As I said, these quibbles are minor. The book is a great reference for any clinician involved in the treatment of patients with mental health problems.
From the Publisher
“This comprehensive guide presents clinicians with evidence-based information on prescribing psychotropic drugs for mental health … This book will help nurses to be confident, sensitive and informed when discussing medication with patients and relatives, exploring treatment options within their professional teams and liaising with allied health professionals.” (Nursing Standard, 30 May 2012)
Read More Show Less

Product Details

  • ISBN-13: 9781118323250
  • Publisher: Wiley
  • Publication date: 2/6/2012
  • Sold by: Barnes & Noble
  • Format: eBook
  • Edition number: 11
  • Pages: 680
  • File size: 6 MB

Meet the Author

David Taylor is Director of Pharmacy and Pathology at the South London and Maudsley NHS Foundation Trust, and Professor of Psychopharmacology at King’s College London.  The lead author of all editions of the Maudsley Prescribing Guidelines, Professor Taylor is the author of several other texts and editor of Therapeutic Advances in Psychopharmacology.

Carol Paton is Chief Pharmacist at Oxleas NHS Foundation Trust, London: she is also joint Head of the Prescribing Observatory for Mental Health and an Honorary Research Fellow at Imperial College London. 

Shitij Kapur is Professor of Schizophrenia, Imaging and Therapeutics and the Dean and Head of School at the Institute of Psychiatry, King's College London.

Read More Show Less

Read an Excerpt

Click to read or download

Read More Show Less

Table of Contents

Preface ix

Acknowledgements x

Notes on using The Maudsley Prescribing Guidelines xi

Notes on inclusion of drugs xi

List of abbreviations xii

Chapter 1 Plasma level monitoring of psychotropic drugs and anticonvulsants 1

Interpreting sample results 2

Chapter 2 Schizophrenia 11

Antipsychotic drugs 11

Antipsychotic drugs: equivalent doses 13

Antipsychotic drugs: minimum effective doses 14

Antipsychotic drugs: licensed maximum doses 16

New antipsychotic drugs 17

Antipsychotic drugs: general principles of prescribing 21

National Institute for Health and Clinical Excellence guidelines for the treatment of schizophrenia 22

Treatment algorithms for schizophrenia 24

Antipsychotic drugs: monitoring of metabolic effects 26

Switching antipsychotic drugs because of poor tolerability 31

Antipsychotic response: to increase the dose, to switch, to add or just wait – what is the right move? 33

Speed and onset of antipsychotic drug action 36

First-generation antipsychotic drugs: place in therapy 39

Antipsychotic drugs: long-acting injections 40

Risperidone long-acting injection 44

Paliperidone palmitate long-acting injection 47

Management of patients on long-term depots: dose reduction 50

Combined antipsychotic drugs 51

High-dose antipsychotic drugs: prescribing and monitoring 54

Negative symptoms in schizophrenia 57

Antipsychotic prophylaxis 60

Refractory schizophrenia and clozapine 64

Clozapine augmentation 66

Refractory schizophrenia: alternatives to clozapine 69

Clozapine: management of common adverse effects 75

Clozapine: uncommon or unusual adverse effects 78

Clozapine: serious haematological and cardiovascular adverse effects 80

Clozapine, neutropenia and lithium 84

Clozapine and chemotherapy 88

Clozapine-related hypersalivation 89

Guidelines for the initiation of clozapine for patients based in the community 92

Omega-3 fatty acids (fish oils) in schizophrenia 96

Extrapyramidal side-effects of antipsychotic drug treatment 98

Treatment of antipsychotic-induced akathisia 103

Treatment of tardive dyskinesia 105

Neuroleptic malignant syndrome 110

Catatonia 113

Cardiovascular effects of antipsychotic drug treatment 115

Antipsychotic drugs and hypertension 122

Hyperprolactinaemia 123

Antipsychotic-induced weight gain 126

Treatment of drug-induced weight gain 128

Antipsychotic drugs, diabetes and impaired glucose tolerance 132

Antipsychotic drugs and dyslipidaemia 138

Antipsychotic drugs and sexual dysfunction 142

Antipsychotic-associated hyponatraemia 148

Antipsychotics and pneumonia 150

Relative adverse effects of antipsychotic drugs: a rough guide 151

Chapter 3 Bipolar disorder 153

Valproate 153

Lithium 159

Carbamazepine 168

Physical monitoring of people with bipolar disorder 173

Treatment of acute mania or hypomania 176

Antipsychotic drugs in bipolar disorder 182

Bipolar depression 185

Rapid cycling bipolar disorder 191

Prophylaxis in bipolar disorder 193

Chapter 4 Depression and anxiety 197

Depression 197

Antidepressants 201

Treatment of resistant depression 222

Treatment of psychotic depression 233

Electroconvulsive therapy and psychotropic drugs 235

Psychostimulants in depression 239

Treatment of depression in the elderly 243

Treatment of depression in stroke 247

Adverse effects of antidepressants 249

Selective serotonin reuptake inhibitors and bleeding 252

Depression and diabetes 255

Cardiac effects of antidepressants 257

Antidepressants and sexual dysfunction 264

Antidepressants and hyperprolactinaemia 268

Antidepressants: swapping and stopping 270

St John’s wort in the treatment of depression 278

Drug interactions with antidepressants 281

Alternative routes of administration for antidepressants 286

Anxiety spectrum disorders 292

Benzodiazepines in the treatment of psychiatric disorders 301

Benzodiazepines and disinhibition 304

Benzodiazepines: dependence and detoxification 306

Insomnia 310

Chapter 5 Children and adolescents 315

Principles of prescribing practice in childhood and adolescence 315

Depression in children and adolescents 316

Bipolar illness in children and adolescents 321

Psychosis in children and adolescents 326

Anxiety in children and adolescents 327

Obsessive compulsive disorder in children and adolescents 328

Attention deficit hyperactivity disorder 332

Autism spectrum disorders 337

Tics and Tourette’s syndrome 345

Melatonin in the treatment of insomnia in children and adolescents 349

Rapid tranquillisation in children and adolescents 351

Doses of commonly used psychotropic drugs in children and adolescents 354

Chapter 6 Substance misuse 355

Alcohol dependence 356

Opioid misuse and dependence 372

Nicotine and smoking cessation 398

Stimulant drugs of dependence 406

Benzodiazepine misuse 407

-Butaryl-lactone and -hydroxybutyrate dependence 408

Drugs of misuse: a summary 410

Interactions between ‘street drugs’ and prescribed psychotropic drugs 414

Chapter 7 Use of psychotropic drugs in special patient groups 419

Epilepsy 419

Pregnancy 430

Breast feeding 446

Renal impairment 462

Hepatic impairment 478

Prescribing in the elderly 487

Dementia 490

Behavioural and psychological symptoms of dementia 509

Parkinson’s disease 518

Multiple sclerosis 522

Eating disorders 527

Acutely disturbed or violent behaviour 531

Psychotropic medications for adults with learning disabilities 539

Borderline personality disorder 545

Delirium 547

Huntington’s disease 554

Psychotropic drugs and surgery 558

Prescribing psychotropic drugs for patients with HIV infection 564

Psychotropic drugs and cytochrome (CYP) function 573

Summary of psychiatric side-effects of non-psychotropic drugs 578

Chapter 8 Miscellaneous conditions and substances 587

Psychotropic drugs in overdose 587

Biochemical and haematological effects of psychotropic drugs 593

Prescribing drugs outside their licensed indications 604

Observations on the placebo effect in mental illness 606

Drug interactions with alcohol 608

Nicotine 613

Smoking and psychotropic drugs 616

Caffeine 618

Complementary therapies 624

Enhancing medication adherence 628

Driving and psychotropic medicines 634

Covert administration of medicines within food and drink 643

Index 647

Read More Show Less

Customer Reviews

Be the first to write a review
( 0 )
Rating Distribution

5 Star

(0)

4 Star

(0)

3 Star

(0)

2 Star

(0)

1 Star

(0)

Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation

Reminder:

  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

 
Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously

    If you find inappropriate content, please report it to Barnes & Noble
    Why is this product inappropriate?
    Comments (optional)